Printer Friendly

AEQUITRON MEDICAL ANNOUNCES THIRD QUARTER EARNINGS

 AEQUITRON MEDICAL ANNOUNCES THIRD QUARTER EARNINGS
 MINNEAPOLIS, Feb. 18 /PRNewswire/ -- Aequitron Medical, Inc.


(NASDAQ: AQTN) announced today net income of $22,700 on sales of $5,518,200 for the ?third quarter ended January 31, 1992. This compares with net income of $168,100, or $.04 per share, on sales of $6,078,100 for the third quarter last year.
 For the nine months ended Jan. 31, 1992, Aequitron reported net income of $540,100, or $.11 per share, on sales of $18,043,100, compared with net income of $880,100, or $.19 per share, on sales of $19,974,000 for the same period a year ago.
 Numerous factors contributed to the slowdown during the quarter including customer cash flow uncertainty caused by reimbursement issues, the seasonal fluctuation of the industry and a lingering recession, according to Aequitron President and CEO Curtis J. Olson. He also cited a temporary reduction in demand from a major international distributor caused by economic conditions in Europe and delays in FDA approval of two new products as factors impacting revenues.
 In an effort to be proactive within the confines of a restrictive economy, Aequitron expects to announce the appointment of key sales, marketing and research and development professionals in the near term. "The economy is obviously outside of our control," said Olson, "but we are optimistic that we will find ways to overcome the difficulties we face by creating opportunities for expansion and diversification."
 In spite of reduced sales, expense controls have allowed us to remain profitable. "We are pleased that we have been able to control expenses to ensure the continued profitability of the company," Olson said.
 "Although the economy continues to be sluggish and the fourth quarter is not likely to achieve last year's levels, we remain optimistic about the future," Olson concluded. "We have sound fundamentals in place and we fully expect to be able to capitalize on this solid foundation in fiscal 1993. We expect to receive FDA approval on at least one new product in the very near future."
 Aequitron Medical, Inc. designs, manufactures and markets electronic products for home health care and hospital use; and wheelchair lifts and automobile hand controls for the mobility impaired. The company's common stock is traded on the National Market System under the NASDAQ symbol AQTN.
 AEQUITRON MEDICAL, INC.
 Third Quarter Ended January 31,
 1992 1991
 Net Sales $ 5,518,200 $ 6,078,100
 Net Income $ 22,700 $ 168,100
 Net Income Per Share $ .00 $ .04
 Weighted Average Number
 of Shares Outstanding 4,741,100 4,694,800
 Nine Months Ended January 31,
 1992 1991
 Net Sales $ 18,043,100 $ 19,974,000
 Net Income $ 540,100(a) $ 880,100
 Net Income Per Share $ .11(a) $ .19
 Weighted Average Number
 of Shares Outstanding 4,734,100 4,694,800
 (a) These numbers include $305,700, or $.065 per share, from the settlement of a vendor claim.
 -0- 2/18/92
 /CONTACT: David Neuger, (Home) 612-699-6730, or Ed Neuger, (Home) 612-929-0945, both of Edwin Neuger & Associates, 612-333-6621, for Aequitron/
 (AQTN) CO: Aequitron Medical, Inc. ST: Minnesota IN: MTC SU: ERN


KH -- MN015 -- 9991 02/18/92 13:37 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 18, 1992
Words:527
Previous Article:A&W BRANDS, INC. ANNOUNCES LICENSING AGREEMENT WITH TETLEY, INC. FOR READY-TO-DRINK ICED TEA
Next Article:HADRON, INC., ANNOUNCES SECOND QUARTER FINANCIAL RESULTS
Topics:


Related Articles
AEQUITRON MEDICAL SECOND QUARTER EARNINGS BOOSTED BY SETTLEMENT WITH VENDOR
AEQUITRON MEDICAL REPORTS FOURTH QUARTER SALES AND EARNINGS
AEQUITRON REPORTS RECORD QUARTERLY SALES AND HIGHER OPERATING EARNINGS FOR SECOND QUARTER
AEQUITRON MEDICAL ANNOUNCES RECORD SALES FOR THIRD QUARTER NET INCOME FOR THE NINE MONTHS UP 60 PERCENT
AEQUITRON MEDICAL EXITS UNPROFITABLE OXYGEN CONCENTRATOR PRODUCT LINE; COMPANY EXPECTS TO ANNOUNCE LOSS FOR FIRST QUARTER
AEQUITRON MEDICAL INCREASES NET INCOME 79 PERCENT FOR THIRD QUARTER
AEQUITRON MEDICAL REPORTS NET EARNINGS UP 25 PERCENT FOR THIRD QUARTER
AEQUITRON MEDICAL ANNOUNCES RECORD FIRST QUARTER SALES AND EARNINGS
AEQUITRON MEDICAL EXPECTS LOWER THIRD QUARTER EARNINGS
AEQUITRON MEDICAL REPORTS RECORD RESULTS FOR ITS FIRST NINE MONTHS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters